Abiomed, Inc. (ABMD) Financials

NASDAQ Currency in USD Disclaimer

$381.02

north_east NA Past Year
Day's range
$380.55
Day's range
$381.28
$1.2B$1.2B$1B$1B$800M$800M$600M$600M$400M$400M$200M$200M$0$0Earning2016201620172017201820182019201920202020202120212022202240%40%35%35%30%30%25%25%20%20%15%15%10%10%Profit Margin
Profit Margin
Revenue
Earnings

ABMD Income statement / Annual

Last year (2022), Abiomed, Inc.'s total revenue was $1.03 B, an increase of 21.74% from the previous year. In 2022, Abiomed, Inc.'s net income was $136.51 M. See Abiomed, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 03/31/2022 03/31/2021 03/31/2020 03/31/2019 03/31/2018 03/31/2017 03/31/2016 03/31/2015 03/31/2014 03/31/2013
Operating Revenue $1.03 B $847.52 M $840.88 M $769.43 M $593.75 M $445.30 M $329.54 M $230.31 M $183.64 M $158.12 M
Cost of Revenue $188.16 M $161.91 M $151.31 M $129.57 M $98.58 M $70.63 M $50.42 M $39.95 M $37.32 M $31.60 M
Gross Profit $843.60 M $685.62 M $689.58 M $639.87 M $495.17 M $374.68 M $279.12 M $190.37 M $146.32 M $126.53 M
Gross Profit Ratio 0.82 0.81 0.82 0.83 0.83 0.84 0.85 0.83 0.8 0.8
Research and Development Expenses $163.40 M $121.88 M $98.76 M $93.50 M $75.30 M $66.39 M $49.76 M $35.97 M $30.71 M $25.65 M
General & Administrative Expenses $0.00 $0.00 $0.00 $321.55 M $262.73 M $218.15 M $164.26 M $125.73 M $107.25 M $84.23 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $423.49 M $334.18 M $341.60 M $321.55 M $262.73 M $218.15 M $164.26 M $125.73 M $107.25 M $84.23 M
Other Expenses $0.00 $51.95 M -$4.56 M $30.38 M -$388,000.00 -$349,000.00 $339,000.00 -$97,000.00 $49,000.00 $326,000.00
Operating Expenses $586.89 M $456.06 M $440.36 M $415.05 M $338.03 M $284.54 M $214.02 M $161.70 M $137.96 M $109.99 M
Cost And Expenses $775.05 M $617.97 M $591.66 M $544.62 M $436.61 M $355.17 M $264.44 M $201.65 M $175.28 M $141.58 M
Interest Income $49.84 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $49.84 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $28.09 M $17.38 M $8.26 M $14.12 M $11.01 M $6.20 M $3.28 M $2.77 M $2.51 M $2.72 M
EBITDA $400.78 M $246.94 M $257.48 M $230.77 M $164.45 M $94.79 M $67.99 M $31.24 M $10.75 M $19.27 M
EBITDA Ratio 0.39 0.29 0.31 0.3 0.28 0.21 0.21 0.14 0.06 0.12
Operating Income Ratio 0.36 0.27 0.3 0.29 0.26 0.2 0.2 0.12 0.05 0.1
Total Other Income/Expenses Net -$182.13 M $58.66 M $7.61 M $38.55 M $3.30 M $1.21 M $734,000.00 $99,000.00 $167,000.00 $319,000.00
Income Before Tax $190.56 M $288.22 M $256.83 M $263.36 M $160.44 M $91.34 M $65.84 M $28.77 M $8.53 M $16.86 M
Income Before Tax Ratio 0.18 0.34 0.31 0.34 0.27 0.21 0.2 0.12 0.05 0.11
Income Tax Expense $54.06 M $62.70 M $53.82 M $4.34 M $48.27 M $39.23 M $27.69 M -$84.92 M $1.18 M $1.85 M
Net Income $136.51 M $225.53 M $203.01 M $259.02 M $112.17 M $52.12 M $38.15 M $113.69 M $7.35 M $15.01 M
Net Income Ratio 0.13 0.27 0.24 0.34 0.19 0.12 0.12 0.49 0.04 0.09
EPS 3 5 4.49 5.77 2.54 1.21 0.9 2.8 0.19 0.38
EPS Diluted 2.98 4.94 4.43 5.61 2.45 1.17 0.85 2.65 0.18 0.37
Weighted Average Shares Out $45.45 M $45.14 M $45.18 M $44.91 M $44.15 M $43.24 M $42.20 M $40.63 M $39.33 M $39.11 M
Weighted Average Shares Out Diluted $45.88 M $45.67 M $45.82 M $46.15 M $45.85 M $44.66 M $44.90 M $42.86 M $41.61 M $41.05 M
Link